Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice

Leonidas Chouliaras, Roy Lardenoije, Gunter Kenis, Diego Mastroeni, Patrick R. Hof, Jim Van Os, Harry W.M. Steinbusch, Fred W. Van Leeuwen, Bart P.F. Rutten, Daniel L.A. Van Den Hove

Research output: Contribution to journalArticle

Abstract

Brain aging has been associated with aberrant DNA methylation patterns, and changes in the levels of DNA methylation and associated markers have been observed in the brains of Alzheimer's disease (AD) patients. DNA hydroxymethylation, however, has been sparsely investigated in aging and AD. We have previously reported robust decreases in 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hippocampus of AD patients compared to non-demented controls. In the present study, we investigated 3- and 9-month-old APPswe/PS1ΔE9 transgenic and wild-type mice for possible age-related alterations in 5-mC and 5-hmC levels in three hippocampal sub-regions using quantitative immunohistochemistry. While age-related increases in levels of both 5-mC and 5-hmC were found in wild-type mice, APPswe/PS1ΔE9 mice showed decreased levels of 5-mC at 9 months of age and no age-related changes in 5-hmC throughout the hippocampus. Altogether, these findings suggest that aberrant amyloid processing impact on the balance between DNA methylation and hydroxymethylation in the hippocampus during aging in mice.

Original languageEnglish (US)
Pages (from-to)190-202
Number of pages13
JournalTranslational Neuroscience
Volume9
Issue number1
DOIs
StatePublished - Dec 31 2018
Externally publishedYes

Fingerprint

5-Methylcytosine
DNA Methylation
Hippocampus
Alzheimer Disease
Brain Diseases
Amyloid
Transgenic Mice
Immunohistochemistry
5-hydroxymethylcytosine
DNA
Brain

Keywords

  • Aging
  • Alzheimer's Disease
  • APPswe/PS1ΔE9
  • DNA hy-droxymethylation
  • DNA methylation
  • Epigenetics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Chouliaras, L., Lardenoije, R., Kenis, G., Mastroeni, D., Hof, P. R., Os, J. V., ... Van Den Hove, D. L. A. (2018). Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice. Translational Neuroscience, 9(1), 190-202. https://doi.org/10.1515/tnsci-2018-0028

Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice. / Chouliaras, Leonidas; Lardenoije, Roy; Kenis, Gunter; Mastroeni, Diego; Hof, Patrick R.; Os, Jim Van; Steinbusch, Harry W.M.; Van Leeuwen, Fred W.; Rutten, Bart P.F.; Van Den Hove, Daniel L.A.

In: Translational Neuroscience, Vol. 9, No. 1, 31.12.2018, p. 190-202.

Research output: Contribution to journalArticle

Chouliaras, L, Lardenoije, R, Kenis, G, Mastroeni, D, Hof, PR, Os, JV, Steinbusch, HWM, Van Leeuwen, FW, Rutten, BPF & Van Den Hove, DLA 2018, 'Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice', Translational Neuroscience, vol. 9, no. 1, pp. 190-202. https://doi.org/10.1515/tnsci-2018-0028
Chouliaras, Leonidas ; Lardenoije, Roy ; Kenis, Gunter ; Mastroeni, Diego ; Hof, Patrick R. ; Os, Jim Van ; Steinbusch, Harry W.M. ; Van Leeuwen, Fred W. ; Rutten, Bart P.F. ; Van Den Hove, Daniel L.A. / Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice. In: Translational Neuroscience. 2018 ; Vol. 9, No. 1. pp. 190-202.
@article{56479a78a5ea455c8dec3be7950220c8,
title = "Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice",
abstract = "Brain aging has been associated with aberrant DNA methylation patterns, and changes in the levels of DNA methylation and associated markers have been observed in the brains of Alzheimer's disease (AD) patients. DNA hydroxymethylation, however, has been sparsely investigated in aging and AD. We have previously reported robust decreases in 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hippocampus of AD patients compared to non-demented controls. In the present study, we investigated 3- and 9-month-old APPswe/PS1ΔE9 transgenic and wild-type mice for possible age-related alterations in 5-mC and 5-hmC levels in three hippocampal sub-regions using quantitative immunohistochemistry. While age-related increases in levels of both 5-mC and 5-hmC were found in wild-type mice, APPswe/PS1ΔE9 mice showed decreased levels of 5-mC at 9 months of age and no age-related changes in 5-hmC throughout the hippocampus. Altogether, these findings suggest that aberrant amyloid processing impact on the balance between DNA methylation and hydroxymethylation in the hippocampus during aging in mice.",
keywords = "Aging, Alzheimer's Disease, APPswe/PS1ΔE9, DNA hy-droxymethylation, DNA methylation, Epigenetics",
author = "Leonidas Chouliaras and Roy Lardenoije and Gunter Kenis and Diego Mastroeni and Hof, {Patrick R.} and Os, {Jim Van} and Steinbusch, {Harry W.M.} and {Van Leeuwen}, {Fred W.} and Rutten, {Bart P.F.} and {Van Den Hove}, {Daniel L.A.}",
year = "2018",
month = "12",
day = "31",
doi = "10.1515/tnsci-2018-0028",
language = "English (US)",
volume = "9",
pages = "190--202",
journal = "Translational Neuroscience",
issn = "2081-3856",
publisher = "de Gruyter",
number = "1",

}

TY - JOUR

T1 - Age-related disturbances in DNA (hydroxy)methylation in APP/PS1 mice

AU - Chouliaras, Leonidas

AU - Lardenoije, Roy

AU - Kenis, Gunter

AU - Mastroeni, Diego

AU - Hof, Patrick R.

AU - Os, Jim Van

AU - Steinbusch, Harry W.M.

AU - Van Leeuwen, Fred W.

AU - Rutten, Bart P.F.

AU - Van Den Hove, Daniel L.A.

PY - 2018/12/31

Y1 - 2018/12/31

N2 - Brain aging has been associated with aberrant DNA methylation patterns, and changes in the levels of DNA methylation and associated markers have been observed in the brains of Alzheimer's disease (AD) patients. DNA hydroxymethylation, however, has been sparsely investigated in aging and AD. We have previously reported robust decreases in 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hippocampus of AD patients compared to non-demented controls. In the present study, we investigated 3- and 9-month-old APPswe/PS1ΔE9 transgenic and wild-type mice for possible age-related alterations in 5-mC and 5-hmC levels in three hippocampal sub-regions using quantitative immunohistochemistry. While age-related increases in levels of both 5-mC and 5-hmC were found in wild-type mice, APPswe/PS1ΔE9 mice showed decreased levels of 5-mC at 9 months of age and no age-related changes in 5-hmC throughout the hippocampus. Altogether, these findings suggest that aberrant amyloid processing impact on the balance between DNA methylation and hydroxymethylation in the hippocampus during aging in mice.

AB - Brain aging has been associated with aberrant DNA methylation patterns, and changes in the levels of DNA methylation and associated markers have been observed in the brains of Alzheimer's disease (AD) patients. DNA hydroxymethylation, however, has been sparsely investigated in aging and AD. We have previously reported robust decreases in 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in the hippocampus of AD patients compared to non-demented controls. In the present study, we investigated 3- and 9-month-old APPswe/PS1ΔE9 transgenic and wild-type mice for possible age-related alterations in 5-mC and 5-hmC levels in three hippocampal sub-regions using quantitative immunohistochemistry. While age-related increases in levels of both 5-mC and 5-hmC were found in wild-type mice, APPswe/PS1ΔE9 mice showed decreased levels of 5-mC at 9 months of age and no age-related changes in 5-hmC throughout the hippocampus. Altogether, these findings suggest that aberrant amyloid processing impact on the balance between DNA methylation and hydroxymethylation in the hippocampus during aging in mice.

KW - Aging

KW - Alzheimer's Disease

KW - APPswe/PS1ΔE9

KW - DNA hy-droxymethylation

KW - DNA methylation

KW - Epigenetics

UR - http://www.scopus.com/inward/record.url?scp=85061113658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061113658&partnerID=8YFLogxK

U2 - 10.1515/tnsci-2018-0028

DO - 10.1515/tnsci-2018-0028

M3 - Article

AN - SCOPUS:85061113658

VL - 9

SP - 190

EP - 202

JO - Translational Neuroscience

JF - Translational Neuroscience

SN - 2081-3856

IS - 1

ER -